Folate receptor-positive circulating tumor cells as a potential biomarker for breast cancer diagnosis
This study investigated the potential of folate receptor-positive circulating tumor cells (FR+CTCs) as a non-invasive biomarker for breast cancer diagnosis and clinical stratification. Between January 2024 and October 2024, 179 breast cancer patients and 38 patients with benign breast diseases were enrolled...